S. Paczesny

S. Paczesny, J. Levine, S. Sarantopoulos, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Multiple functional variants in the IL1RL1 region are pretransplant markers for risk of GVHD and infection deaths.

Lara E Sucheston-Campbell, Abbas A. Rizvi, C. Haiman, 2019, Blood advances.

Translational research efforts in biomarkers and biology of early transplant-related complications.

M. Díaz-Ricart, S. Paczesny, K. Cooke, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ICOSL+ plasmacytoid dendritic cells as inducer of graft-versus-host disease, responsive to a dual ICOS/CD28 antagonist

E. Rickel, Hao Liu, S. Dillon, 2020, Science Translational Medicine.

Introduction to a review series on emerging immunotherapies for hematologic diseases.

C. Bollard, S. Paczesny, S. Pavletic, 2018, Blood.

Measuring Melanoma-Specific Cytotoxic T Lymphocytes Elicited by Dendritic Cell Vaccines with a Tumor Inhibition Assay In Vitro

J. Fay, J. Banchereau, A. Palucka, 2005, Journal of immunotherapy.

Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment

S. Farag, M. A. Abu Zaid, S. Paczesny, 2017, International journal of molecular sciences.

Granzyme A–producing T helper cells are critical for acute graft-versus-host disease

S. Janga, M. Kaplan, M. Kazemian, 2020, JCI insight.

Discovery and validation of graft-versus-host disease biomarkers.

S. Paczesny, 2011, Blood.

Phase 1/2 trial of vorinostat plus tacrolimus and mycophenolate to prevent graft versus host disease following related donor reduced intensity conditioning allogeneic hematopoietic stem cell transplantation

J. Dipersio, C. Dinarello, Thomas Braun, 2014 .

Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study.

J. Bolaños-Meade, Juan Wu, S. Paczesny, 2012, Blood.

Proteomic Characterization Reveals That MMP‐3 Correlates With Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Cell and Lung Transplantation

Y. Ogata, P. Gafken, J. Hansen, 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

S. Paczesny, Bryan J Fiema, K. Lamiman, 2012, Journal of visualized experiments : JoVE.

Diagnostic and Prognostic Plasma Biomarkers for Idiopathic Pneumonia Syndrome after Hematopoietic Cell Transplantation.

W. Leisenring, M. Boeckh, S. Paczesny, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.

S. Hanash, J. Greenson, Qing Zhang, 2016, JCI insight.

Graft-Versus-Host Disease–Free Antitumoral Signature AfterAllogeneic Donor Lymphocyte Injection Identified by Proteomics and SystemsBiology

Qing, S. Hanash, J. Chen, 2019 .

Graft-Versus-Host Disease–Free Antitumoral Signature After Allogeneic Donor Lymphocyte Injection Identified by Proteomics and Systems Biology

S. Hanash, J. Chen, Z. Yue, 2019, JCO precision oncology.

Structure-Activity relationship of 1-(Furan-2ylmethyl)Pyrrolidine-Based Stimulation-2 (ST2) inhibitors for treating graft versus host disease.

Chao-yie Yang, J. Stuckey, Krishnapriya Chinnaswamy, 2022, Bioorganic & medicinal chemistry.

A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease

M. Arbushites, S. Paczesny, G. Socié, 2019, British journal of haematology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.

G. Cuvelier, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

Immunotherapy through T-cell receptor gene transfer induces severe graft-versus-host disease.

S. Paczesny, J. Ferrara, P. Reddy, 2010, Immunotherapy.

K E ywords: autoimmunity n graft-versus-host disease n immunotherapy n mixed dimers n TC r cross-pairing n TCR gene therapy n TCR gene transfer n self-reactivity James Ferrara

S. Paczesny, P. Reddy, 2010 .

Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9

J. Renauld, R. Flavell, M. Kaplan, 2022, Nature communications.

Dendritic cells: controllers of the immune system and a new promise for immunotherapy.

J. Fay, V. Pascual, J. Banchereau, 2003, Annals of the New York Academy of Sciences.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report.

J. Pidala, H. Greinix, V. Bhatt, 2021, Transplantation and cellular therapy.

Specific class I HLA supertypes but not HLA zygosity or expression are associated with outcomes following HLA-matched allogeneic hematopoietic cell transplant: HLA supertypes impact allogeneic HCT outcomes.

V. Brown, K. Hsu, Stephanie J. Lee, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients.

T. Braun, S. Choi, S. Paczesny, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

T. Braun, S. Hanash, J. Ritz, 2013, The New England journal of medicine.

Efficient generation of CD34+ progenitor‐derived dendritic cells from G‐CSF‐mobilized peripheral mononuclear cells does not require hematopoietic stem cell enrichment

Jing-ping Ou-yang, A. Eljaafari, S. Paczesny, 2007, Journal of leukocyte biology.

Mesenchymal stem cells for treatment and prevention of graft-versus-host disease after allogeneic hematopoietic cell transplantation.

M. Imamura, S. Paczesny, T. Toubai, 2009, Current stem cell research & therapy.

Spontaneous Proliferation and Type 2 Cytokine Secretion by CD4+T Cells in Patients with Metastatic Melanoma Vaccinated with Antigen-Pulsed Dendritic Cells

H. Ueno, J. Connolly, J. Fay, 2005, Journal of Clinical Immunology.

Single Injection of CD34+ Progenitor-Derived Dendritic Cell Vaccine Can Lead to Induction of T-Cell Immunity in Patients With Stage IV Melanoma

R. Steinman, J. Fay, J. Banchereau, 2003, Journal of immunotherapy.

A biomarker panel for risk of early respiratory failure following hematopoietic cell transplantation

Philip R. Gafken, C. Bollard, S. Farag, 2022, Blood advances.

Biomarkers in chronic graft-versus-host disease: quo vadis?

E. Weissinger, E. Holler, J. Hansen, 2018, Bone Marrow Transplantation.

Number of HLA mismatched eplets is not associated with major outcomes in haploidentical transplantation with post-transplantation cyclophosphamide: A Center for International Blood and Marrow Transplant Research Study.

M. Aljurf, R. Gale, Stephanie J. Lee, 2021, Transplantation and cellular therapy.

Regenerating islet-derived protein 3-α is a prognostic biomarker for gastrointestinal chronic graft-versus-host disease

Stephanie J. Lee, S. Paczesny, D. Couriel, 2022, Blood advances.

Current Definitions and Clinical Implications of Biomarkers in Graft Versus Host Disease.

S. Paczesny, Denggang Fu, A. Bidgoli, 2022, Transplantation and cellular therapy.

Prognostic plasma biomarkers of early complications and graft‐versus‐host disease in patients undergoing allogeneic hematopoietic stem cell transplantation

B. George, K. Lakshmi, P. Balasubramanian, 2020, EJHaem.

Biomarkers for Early Complications After Hematopoietic Stem Cell Transplantation.

S. Paczesny, C. Rowan, 2019, Clinics in laboratory medicine.

Editorial: Danger Signals Triggering Immune Response and Inflammation

S. Paczesny, W. Land, A. Ramadan, 2017, Front. Immunol..

Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT.

M. A. Abu Zaid, Juan Wu, S. Choi, 2017, Blood.

Frequency of CD4 + CD25 hi FOXP3 + Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-Versus-Host Disease.

T. Braun, S. Mineishi, S. Choi, 2009 .

diagnosis and management of acute and Chronic graft-versus-host disease

S. Farag, S. Paczesny, 2014 .

Ex vivo culture of mouse skin activates an interleukin 1 alpha‐dependent inflammatory response

M. Kaplan, D. Spandau, S. Paczesny, 2020, Experimental dermatology.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report Transplantation and Cellular Therapy

J. Pidala, H. Greinix, V. Bhatt, 2021 .

Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.

Nathan H. Roy, Philip R. Gafken, Y. Ogata, 2018, Blood.

The IL-33 Receptor/ST2 acts as a positive regulator of functional mouse bone marrow hematopoietic stem and progenitor cells

H. Broxmeyer, S. Paczesny, S. Cooper, 2020, Blood cells, molecules & diseases.

ST2 as checkpoint target for colorectal cancer immunotherapy.

G. Sandusky, Hua Jiang, Yujing Li, 2020, JCI insight.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report Transplantation and Cellular Therapy

Shannon R. McCurdy, R. Jenq, R. Lafyatis, 2021 .

CXCL10: most consistent cGVHD biomarker?

M. A. Abu Zaid, S. Paczesny, Sophie Paczesny, 2016, Blood.

Protection of mice against leukemia after vaccination with bone marrow-derived dendritic cells loaded with apoptotic leukemia cells.

D. Klatzmann, J. Salzmann, S. Paczesny, 2001, Cancer research.

Advances in Brief Protection of Mice against Leukemia after Vaccination with Bone Marrow-derived Dendritic Cells Loaded with Apoptotic Leukemia Cells 1

D. Klatzmann, J. Salzmann, S. Paczesny, 2001 .

Blueprint for the discovery of biomarkers of toxicity and efficacy for CAR T cells and T-cell engagers.

M. Perales, M. Pasquini, V. Staedtke, 2021, Blood advances.

Combined heterozygosity of FLT3ITD, TET2, and DNMT3A results in aggressive leukemia

Chi Zhang, M. Kelley, S. Paczesny, 2022, JCI insight.

graft-versus-host disease Etanercept plus methylprednisolone as initial therapy for acute

T. Braun, S. Mineishi, S. Choi, 2009 .

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease.

T. Braun, S. Mineishi, S. Choi, 2007, Blood.

TNF-inhibition with etanercept for graft-versus-host disease prevention in high-risk HCT: lower TNFR1 levels correlate with better outcomes.

Scott E. Smith, T. Braun, D. Hanauer, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Three Biomarker Panel at Day 7 and 14 Can Predict Development of Grade II-IV Acute Graft-Versus-Host Disease

T. Braun, S. Hanash, S. Mineishi, 2010 .

Boosting Vaccinations with Peptide-Pulsed CD34+ Progenitor-Derived Dendritic Cells Can Expand Long-Lived Melanoma Peptide-Specific CD8+ T Cells in Patients with Metastatic Melanoma

H. Ueno, J. Fay, J. Banchereau, 2005, Journal of immunotherapy.

Biomarkers for fatal immune response to stem cell treatment could reduce mortality.

S. Paczesny, 2014, Biomarkers in medicine.

Graft-versus-host disease treatment beyond corticosteroids in newly diagnosed patients?

S. Paczesny, 2022, The Lancet. Haematology.

Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes.

T. Braun, D. Hanauer, S. Choi, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Haploidentical Vs. Matched Unrelated Donor Transplants Using Post-Transplant Cyclophosphamide for Lymphoma: A Joint CIBMTR/EBMT Study

D. Blaise, P. Dreger, Stephanie J. Lee, 2021, Blood.

Signatures of GVHD and Relapse after Post-Transplant Cyclophosphamide Revealed by Immune Profiling and Machine Learning.

Shannon R. McCurdy, R. Varadhan, Richard J. Jones, 2021, Blood.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

J. Wingard, J. Gea-Banacloche, S. Paczesny, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.

Shannon R. McCurdy, R. Jenq, G. Cuvelier, 2021, Transplantation and cellular therapy.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report

G. Cuvelier, J. Pidala, H. Greinix, 2021, Transplantation and cellular therapy.

Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.

T. Braun, S. Choi, S. Paczesny, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Validation of genetic associations with acute GVHD and nonrelapse mortality in DISCOVeRY-BMT.

Lara E Sucheston-Campbell, Abbas A. Rizvi, Lara E. Sucheston-Campbell, 2019, Blood advances.

Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34+ progenitor-derived dendritic cells

H. Ueno, J. Fay, J. Banchereau, 2006, Cancer Immunology, Immunotherapy.

An overview of multiplexed analyses of CAR T-cell therapies: insights and potential

S. Paczesny, A. Bidgoli, B. P. DePriest, 2021, Expert review of proteomics.

Various Forms of Tissue Damage and Danger Signals Following Hematopoietic Stem-Cell Transplantation

S. Paczesny, A. Ramadan, 2014, Front. Immunol..

From proteomics to discovery of first-in-class ST2 inhibitors active in vivo.

Greg L. Hura, J. Stuckey, Krishnapriya Chinnaswamy, 2018, JCI insight.

Dendritic cells as vectors for immunotherapy of cancer.

H. Ueno, J. Fay, A. Palucka, 2003, Seminars in cancer biology.

An IL-9–pulmonary macrophage axis defines the allergic lung inflammatory environment

J. Renauld, R. Flavell, M. Kaplan, 2022, Science Immunology.

Mouse pulmonary interstitial macrophages mediate the pro-tumorigenic effects of IL-9

J. Renauld, R. Flavell, M. Kaplan, 2022, Nature Communications.

The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases

S. Paczesny, B. Griesenauer, 2017, Front. Immunol..

Biomarkers for Allogeneic HCT Outcomes

S. Paczesny, Jinfeng Yang, C. Rowan, 2020, Frontiers in Immunology.

Treatment of B-lymphoproliferative disorder with a monoclonal anti-interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial.

A. Fischer, E. Haddad, A. Durandy, 2001, Blood.

Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities

D. Monos, T. Olson, A. Bertuch, 2022, JCI insight.

The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease.

J. Ritz, D. Miklos, M. V. D. van den Brink, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation

J. Crowe, M. Rock, S. Yoder, 2016, Haematologica.

Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial.

T. Braun, J. Dipersio, C. Dinarello, 2014, The Lancet Oncology.

Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings

Jacob J. Kennedy, J. Manson, S. Hanash, 2009, Genome Medicine.

National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report.

D. Miklos, J. Pidala, E. Russek-Cohen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Aqueous two-phase systems enable multiplexing of homogeneous immunoassays.

Shuichi Takayama, Katsuo Kurabayashi, Nien-Tsu Huang, 2014, Technology.

Clofarabine and Busulfan Conditioning Facilitates Engraftment and Provides Significant Anti-Tumor Activity in Non-Remission Hematologic Malignancies Running Title: CloBu4 conditioning for HSCT

T. Braun, K. Elenitoba-Johnson, S. Mineishi, 2016 .

Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies.

T. Braun, K. Elenitoba-Johnson, S. Mineishi, 2011, Blood.

Post‐haematopoietic cell transplantation outcomes: why ST2 became a ‘golden nugget’ biomarker

S. Paczesny, 2020, British journal of haematology.

Clinical Proteomics for Post‐Hematopoeitic Stem Cell Transplantation Outcomes

J. Metzger, S. Paczesny, 2018, Proteomics. Clinical applications.

Biomarkers for posttransplantation outcomes.

S. Paczesny, 2018, Blood.

Plasma biomarkers of lower gastrointestinal and liver acute GVHD.

Thomas M Braun, Sophie Paczesny, Takanori Teshima, 2012, Blood.

Elafin Is a Biomarker of Graft-Versus-Host Disease of the Skin

Thomas M Braun, Hong Wang, Ying Wang, 2008, Science Translational Medicine.

Opportunities and challenges of proteomics in pediatric patients: Circulating biomarkers after hematopoietic stem cell transplantation as a successful example

R. Krance, K. Leung, C. Bollard, 2014, Proteomics. Clinical applications.

Graft-versus-host disease biomarkers: omics and personalized medicine

S. Brooks, S. Paczesny, N. Raiker, 2013, International Journal of Hematology.

Biomarkers for the detection of graft-versus-host disease in cancer patients after bone marrow transplantation

S. Paczesny, 2012 .

A biomarker panel for acute graft-versus-host disease.

Thomas M Braun, Dawn Jones, Sophie Paczesny, 2009, Blood.

Plasma biomarkers in GVHD: a new era?

T. Braun, S. Paczesny, J. Levine, 2009 .

Plasma biomarkers in graft-versus-host disease: a new era?

Thomas M Braun, Sophie Paczesny, T. Braun, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA Informs Risk Predictions after Haploidentical Stem Cell Transplantation with Post-transplantation Cyclophosphamide.

Shannon R. McCurdy, M. Grunwald, Stephanie J. Lee, 2021, Blood.

High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.

J. Goldberg, M. Perales, R. Jenq, 2015, Blood.

Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide

Shannon R. McCurdy, E. Warren, S. Perkins, 2017, Haematologica.

Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation.

S. Hanash, N. Vélez de Mendizábal, R. Bies, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic biomarkers for acute graft-versus-host disease risk after cyclophosphamide-fludarabine nonmyeloablative allotransplantation.

R. Nelson, S. Perkins, S. Paczesny, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease.

Thomas M Braun, Sophie Paczesny, Elisabeth Huber, 2011, Blood.

Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.

Thomas Braun, Dawn Jones, Sophie Paczesny, 2008, Blood.

Frequency of CD4(+)CD25(hi)FOXP3(+) regulatory T cells has diagnostic and prognostic value as a biomarker for acute graft-versus-host-disease.

T. Braun, S. Mineishi, S. Choi, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease.

S. Hanash, B. Storer, Stephanie J. Lee, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association of plasma CD 163 concentration with de novo-onset chronic graft-versus-host disease

S. Hanash, Stephanie J. Lee, J. Hansen, 2017 .

Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation

Stephanie J. Lee, S. Marsh, S. Spellman, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HLA-DQ + CD4 help = graft-versus-tumor effect.

S. Paczesny, A. Bidgoli, 2022, Blood.

Neonatal hyperoxia promotes asthma‐like features through IL‐33–dependent ILC2 responses

M. Kaplan, H. Kita, Y. Prakash, 2017, The Journal of allergy and clinical immunology.

Upper gastrointestinal acute graft-versus-host disease adds minimal prognostic value in isolation or with other graft-versus-host disease symptoms as currently diagnosed and treated

S. Nikiforow, H. Nakasone, J. Pidala, 2018, Haematologica.

The search for drug-targetable diagnostic, prognostic and predictive biomarkers in chronic graft-versus-host disease

S. Paczesny, Djamilatou Adom, H. Ren, 2018, Expert review of clinical immunology.

Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation

V. Bhatt, Stephanie J. Lee, B. Shaw, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.

J. Ritz, J. Serody, Jianfei Yang, 2017, JCI insight.

T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor

Hua Jiang, S. Paczesny, Denggang Fu, 2021, Frontiers in Immunology.

Specifically differentiated T cell subset promotes tumor immunity over fatal immunity

M. Kaplan, H. Hanenberg, S. Paczesny, 2017, The Journal of experimental medicine.

Biomarker Panel for Chronic Graft-Versus-Host Disease.

Philip R. Gafken, Y. Ogata, B. Storer, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expansion of Melanoma-specific Cytolytic CD8+ T Cell Precursors in Patients with Metastatic Melanoma Vaccinated with CD34+ Progenitor-derived Dendritic Cells

J. Fay, A. Palucka, J. Banchereau, 2004, The Journal of experimental medicine.

A Biomarker Panel for Chronic Graft-Versus-Host Disease

Y. Ogata, B. Storer, Qing Zhang, 2015 .

Loss of epigenetic regulator TET2 and oncogenic KIT regulate myeloid cell transformation via PI3K pathway.

S. Janga, B. Vanhaesebroeck, S. Paczesny, 2018, JCI insight.

Donor HLA-E Status Associates with Disease-Free Survival and Transplant-Related Mortality after Non In Vivo T Cell-Depleted HSCT for Acute Leukemia

K. Hsu, Stephanie J. Lee, S. Spellman, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immunotherapy via dendritic cells.

C. Aspord, J. Fay, V. Pascual, 2005, Advances in experimental medicine and biology.

Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell Transplantation

V. Brown, B. Vincent, D. Miklos, 2021, Transplantation and Cellular Therapy.

severity and incidence of GVHD and survival week after myeloablative allogeneic transplantation correlates with Change in plasma tumor necrosis factor receptor 1 levels in the first

T. Braun, S. Mineishi, S. Paczesny, 2013 .

Antigen-specific T cell responses correlate with decreased occurrence of acute GVHD in a multicenter contemporary cohort

C. Bollard, S. Paczesny, E. Chorvinsky, 2021, Bone Marrow Transplantation.

Assessment of ST2 for risk of death following graft-versus-host disease in the pediatric and adult age groups.

S. Hanash, R. Krance, Hao Liu, 2020, Blood.

Early high plasma ST2, the decoy IL-33 receptor, in children undergoing hematopoietic cell transplantation is associated with the development of post-transplant diabetes mellitus

S. Paczesny, C. Rowan, E. Moser, 2020, Haematologica.

Acute Graft-Versus-Host Disease Prognosis: Are Biomarkers Ready for Preemptive Clinical Trials?

S. Paczesny, 2017, Clinical chemistry.

Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.

D. K. Jung, A. Kassim, S. Paczesny, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system

P. Muranski, A. Barrett, S. Paczesny, 2016, Bone Marrow Transplantation.

Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes

T. Braun, D. Hanauer, S. Choi, 2014, Bone Marrow Transplantation.

Haploidentical versus matched unrelated donor transplants using post-transplant cyclophosphamide for lymphomas.

D. Blaise, P. Dreger, Stephanie J. Lee, 2022, Transplantation and cellular therapy.

SNPs and prognosis of GvHD before HCT: any progress?

D. Miklos, S. Paczesny, M. Zaid, 2016, Bone Marrow Transplantation.

Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling

J. Manson, S. Hanash, Pei Wang, 2010, Genome Medicine.

Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.

S. Hanash, Matthew Fitzgibbon, M. McIntosh, 2008, Journal of proteome research.